KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables RefundsShares IssuedShares OutstandingShares Repurchased
Ratios

Sarepta Therapeutics (SRPT) Shares Issued: 2011-2025

Historic Shares Issued for Sarepta Therapeutics (SRPT) over the last 14 years, with Sep 2025 value amounting to $2.8 million.

  • Sarepta Therapeutics' Shares Issued fell 79.51% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $78.6 million, marking a year-over-year increase of 1.13%. This contributed to the annual value of $51.2 million for FY2023, which is 70.58% up from last year.
  • Latest data reveals that Sarepta Therapeutics reported Shares Issued of $2.8 million as of Q3 2025, which was down 79.51% from $13.8 million recorded in Q3 2024.
  • Over the past 5 years, Sarepta Therapeutics' Shares Issued peaked at $39.9 million during Q2 2024, and registered a low of $339,000 during Q2 2022.
  • For the 3-year period, Sarepta Therapeutics' Shares Issued averaged around $16.2 million, with its median value being $14.6 million (2023).
  • In the last 5 years, Sarepta Therapeutics' Shares Issued slumped by 99.19% in 2021 and then soared by 1,628.91% in 2023.
  • Sarepta Therapeutics' Shares Issued (Quarterly) stood at $2.1 million in 2021, then surged by 426.21% to $11.3 million in 2022, then crashed by 82.81% to $1.9 million in 2023, then fell by 10.70% to $13.8 million in 2024, then plummeted by 79.51% to $2.8 million in 2025.
  • Its last three reported values are $2.8 million in Q3 2025, $13.8 million for Q3 2024, and $39.9 million during Q2 2024.